ArticleFrontiers in oncology2014

Circulating Type-1 Anti-Tumor CD4(+) T Cells are Preferentially Pro-Apoptotic in Cancer Patients.

Amy K Wesa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.